Randomized Evaluation of Glycemic Control in the Medical Intensive Care Unit Using Real-Time Continuous Glucose Monitoring (REGIMEN Trial)
- 1 December 2015
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 17 (12) , 889-898
Abstract
Background and Objective: Hyperglycemia occurs commonly in patients admitted to medical intensive care units (MICUs). Whether real-time (RT) continuous glucose monitoring (CGM) improves glycemic control and variability and reduces hypoglycemia in severely ill MICU patients with an Acute Physiology and Chronic Health Evaluation II (APACHE-II) score of ≥20 has not been studied. Subjects and Methods: Thirty-five patients (66 ± 10 years of age; APACHE-II score, 28 ± 6) were randomly assigned to RT-CGM ( n = 16) using the GlucoDay ® S (A. Menarini Diagnostics, Florence, Italy) device or to blinded CGM. Insulin was infused using a modified Yale protocol targeting a blood glucose level between 80 and 120 mg/dL. Outcome measures were percentage of time in normoglycemia (80–110 mg/dL) and in hypoglycemia (<60 mg/dL), glycemic variability (SD, coefficient of variation, mean amplitude of glucose excursions, and mean of daily differences), and CGM accuracy (error grid analyses, Bland–Altman bias plot, and mean absolute relative deviation). Results: During 96 h of monitoring, glycemia reached target (80–110 mg/dL) in 37 ± 15%, was between 70 and 180 mg/dL in 91 ± 10%, and <60 mg/dL in 2 ± 2% of the time. In the RT-CGM group glycemia averaged 119 ± 17 mg/dL versus 122 ± 11 mg/dL in the control group. Parameters of glucose variability and percentages of time at target glycemia and in hypoglycemia were similar between groups. GlucoDayS values and arterial glycemia correlated well, with 98.6% of data falling in Zones A and B of the error grid analysis. Mean absolute relative devation was 11.2%. Conclusions: RT-CGM did not ameliorate glucose control or variability; neither did it reduce the number of hypoglycemic events, but our insulin infusion protocol led to overall good glucose control without a significant hypoglycemia risk, making further improvement difficult.Keywords
This publication has 43 references indexed in Scilit:
- Glycemic Control in the ICUNew England Journal of Medicine, 2010
- Dynamic characteristics of blood glucose time series during the course of critical illness: Effects of intensive insulin therapy and relative association with mortality*Critical Care Medicine, 2010
- A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol studyIntensive Care Medicine, 2009
- Intensive versus Conventional Glucose Control in Critically Ill PatientsNew England Journal of Medicine, 2009
- Glycemic variability: A strong independent predictor of mortality in critically ill patients*Critical Care Medicine, 2008
- Glucose Control and Use of Continuous Glucose Monitoring in the Intensive Care Unit: A Critical ReviewCurrent Diabetes Reviews, 2008
- Intensive Insulin Therapy and Pentastarch Resuscitation in Severe SepsisNew England Journal of Medicine, 2008
- Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill PatientsAnesthesiology, 2006
- Intensive Insulin Therapy in the Medical ICUNew England Journal of Medicine, 2006
- Intensive Insulin Therapy in Critically Ill PatientsNew England Journal of Medicine, 2001